News Focus
News Focus
icon url

PURA VIDA

09/19/22 2:57 PM

#1378 RE: PURA VIDA #1377

Interesting volume and price increase (20%) coming in today between 2 and 2:30
Took it right up to the 200EMA on a 30 minute chart and stopped right there at .28
No news that I can see. (insiders or loose lips?) It's happened numerous times
before but only when Robby was CEO only to come right back down over the following
few days..
icon url

Mr Taken

09/30/22 2:19 AM

#1404 RE: PURA VIDA #1377

Been gone for a bit, but nothing seems to have changed except......... All the past employees of Cure (the public traded company) were let go, and then hired back by the newly privatized Cure Pharmaceutical the next day to run the new private division investment that was bought for $20MM. Guess who the CEO is of that new private division... Rob Davidson! Same individual who was let go as CEO when the sale went through. He also left with an additional 500,000 shares of public stock and a payoff of cash. Also gone is the CFO.... another executive now in the privatized division.

So when the sale was made public it was stated that CURE sold off patents and IP in order to pay down debt and refocus. How can you refocus when all you have is two individuals on staff, a CEO, and newly hired CFO at $220K a year salary (none of whom do any manufacturing or production work) and no IP to work from.

Seems to me shareholders have been told how great this will be for their investment, while really there is nothing left to the "old Cure", and Mr. Rob walked away with everything including the staff who know how to actually work, the IP and patents that can actually make money, all his bad private investor solicitations paid off, a bump in salary, even more shares in the soon to be defunct CURE (which he can then write-off as lost investments on his taxes), and the freedom to once again run a company without having to be held accountable to SEC because it is now a private entity.

Bernie would be proud!! Ponzy from the get go and just an empty bag left behind.